BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $224,000 | -1.3% | 200,000 | 0.0% | 0.00% | – |
Q1 2019 | $227,000 | +1.8% | 200,000 | 0.0% | 0.00% | – |
Q4 2018 | $223,000 | -7.1% | 200,000 | 0.0% | 0.00% | – |
Q3 2018 | $240,000 | +1.3% | 200,000 | 0.0% | 0.00% | – |
Q2 2018 | $237,000 | +7.7% | 200,000 | 0.0% | 0.00% | – |
Q1 2018 | $220,000 | -7.2% | 200,000 | 0.0% | 0.00% | – |
Q4 2017 | $237,000 | -87.2% | 200,000 | -87.1% | 0.00% | -100.0% |
Q3 2017 | $1,849,000 | -22.6% | 1,545,000 | -23.1% | 0.00% | 0.0% |
Q2 2017 | $2,390,000 | +6.6% | 2,009,000 | +5.7% | 0.00% | 0.0% |
Q1 2017 | $2,243,000 | -45.3% | 1,900,000 | -45.7% | 0.00% | -50.0% |
Q4 2016 | $4,103,000 | +143.8% | 3,500,000 | +159.3% | 0.00% | +100.0% |
Q3 2016 | $1,683,000 | -9.0% | 1,350,000 | +7844.0% | 0.00% | 0.0% |
Q2 2016 | $1,850,000 | -67.0% | 16,994 | -99.6% | 0.00% | -71.4% |
Q3 2015 | $5,601,000 | +603.6% | 4,168,000 | +733.6% | 0.01% | +600.0% |
Q2 2015 | $796,000 | -81.8% | 500,000 | -82.7% | 0.00% | -75.0% |
Q1 2015 | $4,369,000 | -55.9% | 2,885,000 | -64.3% | 0.00% | -55.6% |
Q4 2014 | $9,903,000 | +10.8% | 8,080,000 | -1.0% | 0.01% | +28.6% |
Q3 2014 | $8,941,000 | +4.0% | 8,165,000 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $8,599,000 | +29.4% | 8,165,000 | +36.4% | 0.01% | 0.0% |
Q1 2014 | $6,643,000 | +21.9% | 5,985,000 | +17.5% | 0.01% | +40.0% |
Q4 2013 | $5,449,000 | – | 5,095,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 5,950,000 | $6,146,000 | 4.56% |
ADVENT CAPITAL MANAGEMENT /DE/ | 37,943,000 | $39,192,000 | 0.73% |
Sonora Investment Management, LLC | 4,670,000 | $4,791,000 | 0.50% |
MIZUHO SECURITIES USA LLC | 5,900,000 | $6,096,000 | 0.36% |
IRON Financial LLC | 430,000 | $446,000 | 0.33% |
RWC Asset Management LLP | 7,300,000 | $7,528,000 | 0.32% |
Calamos Advisors LLC | 49,525,000 | $51,243,000 | 0.28% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 5,777,000 | $5,977,000 | 0.24% |
PALISADE CAPITAL MANAGEMENT, LP | 5,721,000 | $5,896,000 | 0.18% |
Calamos Wealth Management LLC | 1,240,000 | $1,283,000 | 0.17% |